Literature DB >> 12482791

Heart failure and the aging population: an increasing burden in the 21st century?

S Stewart1, K MacIntyre, S Capewell, J J V McMurray.   

Abstract

BACKGROUND: Despite an overall decline in age adjusted mortality from coronary heart disease in developed countries, the number of patients with heart failure may be increasing.
OBJECTIVE: To project the future burden of heart failure in Scotland from contemporary epidemiological data.
METHODS: Scotland, like many industrialised countries, has an aging though numerically stable population (5.1 million). Current estimates of prevalence, general practice (GP) consultation rates, and hospital admission rates related to heart failure were applied to the whole Scottish population. These estimates were then projected over the period 2000 to 2020, on an age and sex specific basis, using expected changes in the age structure of the Scottish population.
RESULTS: There are currently estimated to be 40 000 men and 45 000 women aged > or = 45 years with heart failure in Scotland. On the basis of population changes alone, these figures will rise in men and women by 2300 (6%) and 1500 (3%) by year 2005, and by 12 300 (31%) and 7800 (17%) in the longer term (2020), respectively. On the same basis, the annual number of male and female GP visits is likely to rise by 6400 (6%) and 2500 (2%) by year 2005, and by 35 200 (40%) and 17 300 (16%) in the longer term (124 000 and 126 000 visits), respectively. In the year 2000 about 3500 men and 4300 women in Scotland had an incident hospital admission for heart failure. By the year 2020 these figures are likely to increase by 52% (1800 more) and 16% (717 more) in men and women, respectively. If recent trends in short term case fatality rates continue to improve, the number of men who survive this event will increase by 59% (1700 more). Overall, by 2020 the annual number of male and female hospital admissions associated with a principal diagnosis of heart failure is expected to increase by 34% (from 5500 to 7500) and by 12% (from 7800 to 8500), respectively.
CONCLUSIONS: Unless rapid and major changes occur in the incidence of heart failure, the burden of this disorder will continue to increase in both primary and secondary care over the next two decades. The greatest increase is likely to occur in men. Future health service planning must take this into account.

Entities:  

Mesh:

Year:  2003        PMID: 12482791      PMCID: PMC1767504          DOI: 10.1136/heart.89.1.49

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.

Authors:  T A McDonagh; C E Morrison; A Lawrence; I Ford; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

Review 2.  Clinical epidemiology of heart failure: public and private health burden.

Authors:  J J McMurray; M C Petrie; D R Murdoch; A P Davie
Journal:  Eur Heart J       Date:  1998-12       Impact factor: 29.983

Review 3.  Disease burden of cardiovascular disease in the elderly.

Authors:  D T Kelly
Journal:  Coron Artery Dis       Date:  1997-10       Impact factor: 1.439

4.  Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey.

Authors:  S Morgan; H Smith; I Simpson; G S Liddiard; H Raphael; R M Pickering; D Mant
Journal:  BMJ       Date:  1999-02-06

5.  Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.

Authors:  A Mosterd; R B D'Agostino; H Silbershatz; P A Sytkowski; W B Kannel; D E Grobbee; D Levy
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

Review 6.  The challenge of health care delivery to the elderly patient with cardiovascular disease. Demographic, epidemiologic, fiscal, and health policy implications.

Authors:  W B Batchelor; J G Jollis; G C Friesinger
Journal:  Cardiol Clin       Date:  1999-02       Impact factor: 2.213

7.  More 'malignant' than cancer? Five-year survival following a first admission for heart failure.

Authors:  S Stewart; K MacIntyre; D J Hole; S Capewell; J J McMurray
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

8.  Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

Authors:  H Tunstall-Pedoe; K Kuulasmaa; M Mähönen; H Tolonen; E Ruokokoski; P Amouyel
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

9.  A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective.

Authors:  R J Goldberg; J Yarzebski; D Lessard; J M Gore
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

10.  Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study.

Authors:  M Davies; F Hobbs; R Davis; J Kenkre; A K Roalfe; R Hare; D Wosornu; R J Lancashire
Journal:  Lancet       Date:  2001-08-11       Impact factor: 79.321

View more
  94 in total

Review 1.  Determinants of heart failure self-care: a systematic literature review.

Authors:  R Oosterom-Calo; A J van Ballegooijen; C B Terwee; S J te Velde; I A Brouwer; T Jaarsma; J Brug
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  Efficacy of the Acorn Cardiac Support Device in animals with heart failure secondary to high rate pacing.

Authors:  John M Power; Jai Raman; Melissa J Byrne; Clif A Alferness
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

3.  The Gordon Wilson lecture: using genetic medicine to regenerate diseased organs and protect against the hostile environment.

Authors:  Timothy P O'Connor; Ronald G Crystal
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

4.  Improving end-of-life care for patients with chronic heart failure.

Authors:  David R Thompson
Journal:  Heart       Date:  2007-08       Impact factor: 5.994

5.  The impact of age on clinical outcomes following cardiac resynchronisation therapy.

Authors:  K Guha; D Konstantinou; L Mantziari; B N Modi; B Chandrasekaran; Z Khalique; T McDonagh; R Sharma
Journal:  J Interv Card Electrophysiol       Date:  2013-11-29       Impact factor: 1.900

Review 6.  Role of Inflammation in Heart Failure.

Authors:  Lily F Shirazi; Joe Bissett; Francesco Romeo; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

7.  Exercise training inducibility of MnSOD protein expression and activity is retained while reducing prooxidant signaling in the heart of senescent rats.

Authors:  John M Lawler; Hyo-Bum Kwak; Jong-Hee Kim; Min-Hwa Suk
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-18       Impact factor: 3.619

8.  Health-related quality of life in unselected outpatients with heart failure across Spain in two different health care levels. Magnitude and determinants of impairment: the INCA study.

Authors:  Beatriz de Rivas; Gaietà Permanyer-Miralda; Carlos Brotons; Joaquín Aznar; Eduardo Sobreviela
Journal:  Qual Life Res       Date:  2008-10-15       Impact factor: 4.147

Review 9.  Is heart failure different on the two continents (North America and Europe)?

Authors:  Rachel Hughes-Doichev; Mark E Dunlap
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

10.  A story of maladies, misconceptions and mishaps: effective management of heart failure.

Authors:  Carol R Horowitz; Stephanie B Rein; Howard Leventhal
Journal:  Soc Sci Med       Date:  2004-02       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.